CDC Researchers Say Pfizer’s and Moderna’s SARS-CoV-2 Vaccines Are Highly Effective At Preventing Symptomatic And Asymptomatic Infections Under Real-World Conditions

March 30, 2021

The New York Times (3/29, Kolata) reports CDC researchers found that Pfizer-BioNTech’s and Moderna’s SARS-CoV-2 vaccines “are proving highly effective at preventing symptomatic and asymptomatic infections under real-world conditions.” The Times adds, “Con...